These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Herpes virus-related antigens in herpes simplex virus type 2-transformed cells in the course of cervical carcinoma.
    Author: Christenson B.
    Journal: Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1345-52. PubMed ID: 6299751.
    Abstract:
    Anticomplement immunofluorescence (ACIF) technique was applied to Herpes simplex virus type 2 (HSV-2)-transformed cells (333-8-9) and to cells lytically infected with HSV-2 in sera from women with cervical carcinoma. There was a correlation between the positive results with both types of cells. Long-term survivors suffering from cervical cancer showed a high percentage of positive immunofluorescence (IF) reactions in HSV-2 transformed cells (77%) as well as in cells lytically infected with HSV-2 (77%) in sera obtained before treatment. The figures were 81 and 83% respectively in sera collected 6-24 months after treatment. When the IFs of survivors and non-survivors were compared, the survivors showed more cytoplasmic staining reactions in sera obtained before treatment than in similar sera from non-survivors, whereas there was no difference in nuclear IF. The sera of survivors taken 6-24 months after treatment had a significantly higher overall fluorescence rate than similar sera from non-survivors. In late sera taken 36 months after treatment, a drop in reactivity was noted for the survivors to values comparable with those obtained from non-survivors. The controls (age-matched, healthy women and patients with malignancies other than cervical carcinoma) showed significantly less IF reactions (P less than 0.001).
    [Abstract] [Full Text] [Related] [New Search]